CRN opens registration to annual meeting
WASHINGTON – The Council for Responsible Nutrition on Tuesday opened registration for the association’s educational/networking events — The Workshop: CRN’s Day of Science and The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry — taking place Nov. 5 to 8 at the Ritz-Carlton, Laguna Niguel in Dana Point, Calif.
Michelle Stout, regulatory policy director at Amway/Nutrilite, and a member of CRN’s board of directors, has been appointed as the 2014 Conference dhair, by CRN chairman John Blair of The Juice Plus+ Company.
The workshop on Nov. 5 is a full-day symposium bringing together scientific experts to focus on relevant dietary supplement/nutrition science, culminating in an evening networking reception that also serves as the opening event for the conference. With two full days (Thursday and Friday) of educational sessions and speakers, the conference will end on Saturday morning following a “Breakfast with …” speaker.
“The CRN events have developed a strong reputation for providing leaders in our industry with valuable updates, fresh perspectives and best practices across regulatory, legal, legislative, science and international disciplines,” Stout said. “This year at The Conference we will build on the success of last year’s event to provide an even broader look at critical industry and business issues, with hands-on, dynamic business and communications sessions. I am honored to serve as conference chair and look forward to welcoming participants to my home state of California.”
QS/1 partnering with VUCA Health to offer on-demand prescription-specific videos
SPARTANBURG, S.C. — QS/1, a complete healthcare automation solutions provider, on Tuesday announced it is partnering with VUCA Health to offer on-demand prescription-specific videos, as well as other services to engage patients and strengthen customer relationships.
QS/1 pharmacies will be able to print QR codes on prescription labels that link to thousands of videos in the MedsOnCue library. The videos help patients review how to take their medications safely with easy to understand information on potential side effects and how to limit any avoidable reactions.
“By partnering with VUCA Health to bring MedsOnCue to our customers, we are taking pharmacy-patient communications to the next level,” stated John Frady, QS/1’s market analyst for the pharmacy market. “MedsOnCue enables our pharmacies to positively impact health literacy and medication adherence by tapping into the power of on-demand video briefings that leverage the ubiquitous nature of mobile communications.”
“Leading-edge companies like QS/1 recognize that coupling digital content with mobile technology creates a powerful platform from which pharmacies can deliver meaningful patient education that overcomes the barriers to medication adherence,” added VUCA Health CEO David Medvedeff.
In addition to the library of videos in English and Spanish, the MedsOnCue solution also includes three customizable services designed to reinforce patient relationships and cultivate pharmacy loyalty: Connect Me, providing “click-to-call” access to client-designated pharmacies or call centers; Remind Me for streamlined registration with a medication alert and reminder program; and Inform Me, providing on-demand access to additional prescription information and health or wellness resources.
Helen of Troy enters VMS market with acquisition of Healthy Directions
EL PASO, Texas — Helen of Troy on Wednesday announced that it has entered into a definitive purchase agreement to acquire Healthy Directions, a supplier of premium doctor-branded vitamins, minerals and supplements, as well as other health products sold directly to consumers.
"Healthy Directions will add another strong pillar to our growing portfolio of market-leading health and wellness businesses that includes thermometers, humidifiers, vaporizers, air purifiers, and water purifiers," stated Julien Mininberg, CEO Helen of Troy. "Healthy Directions is poised to continue capitalizing on the expected growth in its market. It has a substantial presence in the premium direct-to-consumer VMS category, a proven track record of growth over the past three years, and initiatives in place to continue its momentum. We also like Healthy Directions’ direct-to-consumer business model, which drives growth by focusing on education, replenishment and customer loyalty with a wide range of high-quality products and programs designed to drive repeat purchases," he said. "Healthy Directions’ direct-to-consumer marketing platform also provides a new capability at Helen of Troy, reaching consumers directly through the internet, phone and direct mail, diversifying our go-to-market vehicles, as opposed to primarily brick and mortar retail and online retailers in our other businesses."
Entering the VMS category is a logical step for Helen of Troy as it continues to capitalize on the health and wellness trend, which builds on Helen of Troy¹s acquisitions of Kaz in December of 2010 and PUR in December of 2011, the company noted. Healthy Directions’ portfolio of supplements and health care products is branded with the names of physicians and nutritional experts in product segments such as heart health, digestive health, joint health, skin care and vision support. It has a strong, innovation pipeline and an advantageous direct marketing and delivery capability, which encourages consumer education and automatic replenishment, the company noted.
The purchase price will be approximately $195 million in cash, subject to certain closing adjustments. Following the closing of the acquisition, Healthy Directions will continue to be based in Bethesda, Md. With net sales of approximately $145 million in calendar year 2013, Healthy Directions is expected to increase Helen of Troy’s revenues by more than 10% on an annualized basis. Healthy Directions grew 8.4% in 2013 compared to 2012, ahead of the industry trend in the VMS market.
The transaction is expected to close during Helen of Troy’s second fiscal quarter, subject to customary closing conditions, including regulatory approval.